Early cancer drug trial halted after just 3 patients
NCT ID NCT05317078
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 33 times
Summary
This early-stage study tested a new drug called AMG 794 in adults with advanced lung, ovarian, or other solid tumors that have a specific protein (claudin 6). The main goals were to check safety and find the right dose. However, the study was stopped early after only 3 people enrolled, so no clear results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cabrini Hospital
Malvern, Victoria, 3144, Australia
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Inselspital Bern
Bern, 3010, Switzerland
-
Monash Medical Centre
Clayton, Victoria, 3168, Australia
-
Southern Oncology Clinical Research Unit
Bedford Park, South Australia, 5042, Australia
-
University of California Irvine
Orange, California, 92868, United States
-
University of California Los Angeles
Los Angeles, California, 90095-1678, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.